Scarica l'app Stockscreener
10.37
4.96%
0.49
Pre-mercato:
10.25
-0.12
-1.16%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché TNXP Giù?
Forum
Previsione
Frazionamento azionario
Tonix Pharmaceuticals Holding Corp Borsa (TNXP) Ultime notizie
Tonix Pharmaceuticals Holding Corp (TNXP) Cash Flow - TradingKey
Tonix Pharmaceuticals Holding Corp - TradingKey
Tonix Pharmaceuticals Holding Corp (TNXP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Tonix Pharmaceuticals Holding Corp. to Host Second Quarter 2026 Financial Results Conference Call and Webcast - Quiver Quantitative
Tonix to discuss second-quarter results on Aug. 10 call - Stock Titan
TNXP|Tonix Pharmaceuticals Holding Corp|Price:10.390|Chg%:+0.510 - TradingKey
Tonix Pharmaceuticals Holding Corp (TNXP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Tonix Pharmaceuticals Holding Corp. Revenue Breakdown – NASDAQ:TNXP - TradingView
Why TNXP Stock Is Suddenly Back On Retail Radar - Stocktwits
Tonix Pharmaceuticals Holding Corp (TNXP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Tonix Pharmaceuticals Holding Corp (TNXP) Institutional Confidence - TradingKey
Tonix Pharmaceuticals Holding Corp (TNXP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TNXP Slips After Hours On Slower Than Expected Launch For Fibromyalgia Drug - Stocktwits
Total debt per share of Tonix Pharmaceuticals Holding Corp. – GETTEX:TPM0 - TradingView
TNXP Stock Dives For Four Straight Sessions — Retail Eyes Drug Pipeline Payoff - Stocktwits
Tonix shares TNX-4800 Lyme disease prevention presentation - Bitget
Tonix Pharmaceuticals (TNXP) Investor presentation Summary - Quartr
Tonix Pharmaceuticals (NASDAQ:TNXP): Can This Penny Stock Deliver? - Kalkine Media
Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models - Sahm
Tonix Pharmaceuticals Announces Publication in the - GlobeNewswire
Precision Trading with Tonix Pharmaceuticals Holding Corp. (TNXP) Risk Zones - Stock Traders Daily
symbol__ Stock Quote Price and Forecast - CNN
Tonix secures Medicare coverage for fibromyalgia drug TONMYA By Investing.com - Investing.com South Africa
Tonix Pharmaceuticals (TNXP) Expands Medicare Coverage for Fibro - GuruFocus
Tonix Expands TONMYA Medicare Coverage with New Payer Agreement (TNXP) - Yahoo Finance
Tonix Pharmaceuticals Secures Major Medicare Deal for TONMYA®, Expanding Fibromyalgia Treatment Access to 145 Million Covered Lives – Minichart - Minichart
Tonix Pharmaceuticals (TNXP) Secures Medicare Coverage for Tonmy - GuruFocus
Tonix Pharmaceuticals Announces Major Managed Medicare Payer Agreement for TONMYA® - The Manila Times
Tonix Pharmaceuticals Adds Medicare Part D Coverage for TONMYA, Expands Sales Force - TradingView
Tonix secures Medicare coverage for fibromyalgia drug TONMYA - Investing.com
Tonix Pharmaceuticals Announces Major Medicare Coverage Agreement for TONMYA, Expanding U.S. Access to Approximately 145 Million Covered Lives - Quiver Quantitative
Tonix Pharmaceuticals (NASDAQ: TNXP) secures PBM Medicare pact, targeting 145M TONMYA covered lives - Stock Titan
Form 4 Tonix Pharmaceuticals Holding Corp For: 9 July By Investing.com - Investing.com Nigeria
Tonix (NASDAQ: TNXP) CFO adds 1,453 shares through 2025 employee stock plan - Stock Titan
Technical Reactions to TNXP Trends in Macro Strategies - Stock Traders Daily
Tonix: 'Hold' Based On Tonmya Payer Expansions And MDD Trial Initiation - Seeking Alpha
Tonix Pharmaceuticals Holding Corp. has enrolled the first patient in its Phase 2 “HORIZON” study of TNX-102 SL (sublingual tablet) for the treatment of major depressive disorder (MDD). - Bitget
1.97%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):